⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8279795 | 0.80 | — | — | |
| SCHEMBL24739 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL4900311 | 0.74 | — | — | |
| SCHEMBL2548752 | 0.74 | — | — | |
| SCHEMBL1261725 | 0.74 | — | — | |
| SCHEMBL23074442 | 0.73 | TDP1 (0.42) | — | |
| SCHEMBL2128293 | 0.73 | TDP1 (1.00) | — | |
| SCHEMBL7063205 | 0.73 | — | — | |
| SCHEMBL14870 | 0.73 | — | — | |
| SCHEMBL5708652 | 0.73 | TDP1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11566023-B2 | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof | AKAGERA MEDICINES, INC. (US) | 2023-01-31 | — | — | US | claimed |
| EP-2571506-B1 | PROCESSES FOR PREPARING MACROLIDES AND KETOLIDES AND INTERMEDIATES THEREFOR | CEMPRA PHARMACEUTICALS INC (US) | 2017-05-10 | — | — | EP | claimed |
| US-4265795-A | ACID SOLUBILIZED | DESOTO, INC. (US) | 1981-05-05 | — | — | US | claimed |
| EP-0027378-A1 | Coating composition for cationic electrocoating from aqueous bath and bath for same | DeSOTO, INC. (US) | 1981-04-22 | — | — | EP | claimed |
| US-4263189-A | FOR ELECTROCOATING | DESOTO, INC. (US) | 1981-04-21 | — | — | US | claimed |
| US-20240115666-A1 | COMPOSITIONS AND METHODS FOR REDUCING GAMMA-GLUTAMYLTRANSFERASE LEVELS | LILE METHOD RESEARCH, LLC (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240108695-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING TUBERCULOSIS AND MRSA | LILE METHOD RESEARCH, LLC (US) | 2024-04-04 | — | — | US | disclosed |
| US-20240108682-A1 | COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS | LILE METHOD RESEARCH, LLC (US) | 2024-04-04 | — | — | US | disclosed |
| US-20240108696-A1 | COMPOSITIONS AND METHODS FOR IMPROVING VACCINE THERAPY | LILE METHOD RESEARCH, LLC (US) | 2024-04-04 | — | — | US | disclosed |
| WO-2024064264-A2 | COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS | LILE METHOD RESEARCH, LLC (US) | 2024-03-28 | — | — | WO | disclosed |
| US-11248162-B2 | Viscosification of aqueous solutions | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2022-02-15 | — | — | US | disclosed |
| US-10800820-B2 | Preparation methods for a novel generation of biological safe KLH products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents | BIOSYN ARZNEIMITTEL GMBH (DE) | 2020-10-13 | — | — | US | disclosed |
| WO-2005032544-A1 | TREATMENT OF MITOCHONDRIAL DISEASES | GALILEO PHARMACEUTICALS, INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2005033092-A1 | CHROMAN DERIVATIVES | GALILEO PHARMACEUTICALS, INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2005033093-A1 | 7,8-BICYCLOALKYL-CHROMAN DERIVATIVES | GALILEO PHARMACEUTICALS, INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| US-20050065149-A1 | Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents | PTC THERAPEUTICS, INC. | 2005-03-24 | — | — | US | disclosed |
| US-20050065150-A1 | Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis | PTC THERAPEUTICS, INC. | 2005-03-24 | — | — | US | disclosed |
| US-20050065099-A1 | Alzheimer's disease; Parkinson's disease; brain disorders; antiepileptic agents; amyotrophic lateral sclerosis; vision defects | EDISON PHARMACEUTICALS, INC. | 2005-03-24 | — | — | US | disclosed |
| US-5849889-A | Oligosaccharide-containing 14 aminosteroid compounds and novel diastereoselective aminosteroid process chemistry | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| US-5593686-A | FOR THE TRANSDERMAL SYSTEMIC ADMINISTRATION OF BOPINDOLOL | SANDOZ LTD. (CH) | 1997-01-14 | — | — | US | disclosed |